Newsletter | February 7, 2024

02.07.24 -- 3 Things You Didn't Hear Coming Out Of JPM

SPONSOR

Webinar: Planning For Success — Key Considerations When Developing Your Combination Product

Learn how to build a clear and comprehensive road map to succeed in combination product development, including how to recognize the potential risk factors and implement mitigation strategies for streamlined success. Click here to learn more.

FEATURED EDITORIAL

3 Things You Didn’t Hear Coming Out Of JPM

You’ve heard San Francisco was buzzing with cautious optimism last month. You’ve seen the M&A activity that’s buoying spirits and you know inflation and interest rates are stabilizing, if not improving. You may not have considered these three trendlines, offered by a guy who spent his time at JPM doing more listening than anything. 

Is Your Bioprocess Facility Truly ‘State-Of-The-Art?’

Biopharmaceutical companies calling their facilities "state-of-the-art" should use the latest, most cutting-edge technologies and techniques. Many say they meet that standard — but do they really?

INDUSTRY INSIGHTS

Utilizing Multiplex ddPCR To Streamline Viral Gene Therapy Workflows

Novel analytical technologies such as ddPCR provide a more rapid and robust approach to nucleic acid quantification for therapeutic development for better sensitivity, accuracy, and precision.

Scale-Up Allogeneic Cell Therapies To Large Patient Populations

Explore how to achieve your therapeutic and commercial goals by utilizing a tried-and-tested standardized approach combined with the latest technology and reliable analytics.

Implement A Risk-Based Approach To Safely Manufacture HPAPIs

As interest in HPAPIs as powerful therapeutic mechanisms continues to grow, drug manufacturers must design thoughtful risk-based containment strategies to protect employees and ensure safety.

Advancing ATMP Fluid Management

In this e-book we explore what ATMPs are, what they can achieve, ATMP fluid management, and ATMP manufacturing challenges, as well as receiving expert answers to common questions.

Best Practices For Multiuse Bioreactor Sterilization

Review the results of studies into the optimal method for cleaning and sterilizing a multiuse bioreactor, headplate, tubing, vent filters, liquid media, and filled liquid addition bottle.

USP <382>- Packaging/Delivery System Integrity

Review the scope and testing procedures required by General Chapter USP <382> Elastomeric Component Functional Suitability in Parenteral Product Packaging/Delivery Systems.

4 Methods For Thermal Stability Assessment Of Proteins

Thermal stability is one of the most common critical quality attributes of therapeutic proteins. Learn about four methods for thermal stability assessment of proteins.

A Globally Unique Capability For Nanoforming HPAPIs

As demand for high-potency active pharmaceutical ingredients (HPAPIs) rises, ensuring your company utilizes specialized facilities with HPAPI handling capabilities is crucial.

Viral Clearance: Something Went Wrong, What Do I Do Now?

Even the strongest study design may encounter issues with achieving sufficient clearance. Learn how to troubleshoot these and manufacturing deviations that impact viral safety.

What To Know About CRISPR Screens And Bulk Spheroid Production

Achieve a more physiologically relevant setting with less reliance on model animals when studying diseases such as cancer through the combination of CRISPR screening and bulk spheroid production.

Successful Clinical Manufacturing: Bearing The Future In Mind

Examine whether you've done all you can as early as possible to minimize errors, reduce contamination risks, and speed up processing time to save unnecessary, non-value-added expenses.

Selecting Optimal Chromatography Resins To Support mAb Purification

Discover key considerations when selecting resin options for mAb purification, including alternatives to the conventional affinity capture step.

Sterile Filtration And Quality Risk Management

Process control is essential for manufacturing sterile products. Explore the role of filtration for bioburden control in quality risk management and contamination control strategies.

Developing Robust mRNA Processes In A cGMP Environment

Explore current and emerging technologies to optimize mRNA manufacturing, especially when considering commercial production and the validation of processes in a cGMP environment.

Turnover Packages For Industrial Construction Projects

If you think of a construction turnover package (TOP) plan in industrial projects as optional, think again. Learn how to manage and execute TOPs to achieve operational readiness.

SPONSOR

SOLUTIONS

hMSC And EV Analytical Services

The Industrial DataOps Solution For Industry 4.0

Grifols Recombinant Protein CDMO

A Guide To Cleaning RNA Contamination For Life Sciences

Cell And Gene Therapies: Changing The Healthcare Landscape

Protein A Chromatography Resin For Improved Process Economy

SOLUTIONS

Webinar: Accelerating Rare Disease Treatments From Concept To Cure

The swift progression from gene discovery to mass vaccination in the development of COVID-19 vaccines has set a remarkable precedent. This comprehensive exploration aims to shed light on the critical aspects of expediting curative therapies, with a focus on the strategic role that CDMOs can play in this transformative journey. Click here to learn more.

Connect With Bioprocess Online: